DRW Securities LLC Takes $5.99 Million Position in iShares Biotechnology ETF (NASDAQ:IBB)

DRW Securities LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 41,139 shares of the financial services provider’s stock, valued at approximately $5,990,000. DRW Securities LLC owned 0.08% of iShares Biotechnology ETF at the end of the most recent quarter.

Several other large investors have also modified their holdings of IBB. Commerce Bank lifted its holdings in shares of iShares Biotechnology ETF by 1.8% during the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock worth $108,234,000 after purchasing an additional 12,921 shares during the period. Main Management ETF Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF by 2.6% during the second quarter. Main Management ETF Advisors LLC now owns 578,835 shares of the financial services provider’s stock worth $79,451,000 after purchasing an additional 14,535 shares during the period. Raymond James Financial Services Advisors Inc. lifted its holdings in shares of iShares Biotechnology ETF by 24.6% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock worth $29,792,000 after purchasing an additional 42,822 shares during the period. Raymond James & Associates lifted its holdings in shares of iShares Biotechnology ETF by 4.4% during the second quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock worth $26,047,000 after purchasing an additional 7,931 shares during the period. Finally, Albion Financial Group UT lifted its holdings in shares of iShares Biotechnology ETF by 0.3% during the third quarter. Albion Financial Group UT now owns 129,980 shares of the financial services provider’s stock worth $18,925,000 after purchasing an additional 356 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 1.4 %

Shares of NASDAQ IBB opened at $137.96 on Monday. The stock has a fifty day moving average price of $143.43 and a 200 day moving average price of $141.87. iShares Biotechnology ETF has a 1-year low of $117.28 and a 1-year high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.